Exogenous Insulin in type 2 DM
|
|
- Marjory Campbell
- 5 years ago
- Views:
Transcription
1 Exogenous Insulin in type 2 DM Russell Scott 2015
2 Part 1: Some basic biochemistry for Insulin absorption and action
3 MY CHECK LIST Factors influencing insulin action: Forgets to inject Amount given Timing of injection Needle length and depth Any retrograde spill Type of Insulin used Position used for injection Local tissue destruction Speed of uptake of Insulin Insulin binding in vivo Receptor uptake of Insulin Post receptor blocking Anti-insulin factors viz adrenaline, cortisol etc
4 Plasma Insulin (µu/ml) Peripheral Insulin Secretion Profile: what we are trying to emulate 75 Breakfast Lunch Dinner :00 8:00 12:00 16:00 20:00 24:00 4:00 Time 8:00 Adapted from White JR, Campbell RK, Hirsch I. Postgraduate Medicine. 2003;113:30-36.
5 Insulin replacement today has many deficiencies It is given peripherally not portally The crucial Insulin-glucagon communication network is destroyed in DM The gut GLP-1 network is also limited The Somatostatin network is non functional The neural network falls over with time
6 So physiological replacement of insulin is not feasible today The best we can do today is to supply insulin to the wrong place at the wrong time, and in the wrong dose
7 BUT: Portal levels are much more abrupt, exaggerated and wildly pulsatile and so all insulin replacement is completely non-physiological Arterialized ( ) and portal vein ( ) levels in 4 patients Song S H et al. JCEM 2000;85: by Endocrine Society
8 Insulins today Produced by recombinant technology Seldom use soluble insulin except iv Rapid absorbing: modified to reduce hexamer formation speeds absorption Long absorbing: Protamine mixture (NPH) slows absorption crystallization delays subcutaneous absorption
9 Hexameric Insulin
10 Insulin Formulations Prandial Rapid-absorbing analogs Aspart Insulin (NovoRapid) Lispro (Humalog) lisine (Apidra) Basal Intermediate-absorbing NPH (Neutral Protamine Hagedorn, Humulin-N Protophane Long-absorbing Insulin Glargine Detemir Insulin Fast-absorbing Regular (neutral) (Actrapid, Humulin-R) NOTE: I try to avoid the use of the term fast acting etc
11 Insulin Formulations Rapid-absorbing analogs plus Protamine suspension Aspart (NovoMix 30, + Flexpen ) LisPro (Humalog Mix 25, Mix 50) Soluble human insulin plus protamine suspension Actrapid - protamine 30/70, 40/60, 50/50 mixes» (Penmix 30, 40, 50) Mixtard 30 (10ml) Humulin R- protamine 30/70 mix (Humulin 30/70; 3ml, 10 ml)
12 All insulin vials or cartridges containing protamine need repeated agitation to ensure complete mixing viz: Humulin N Protaphane Humulin 30/70 Humalog mix 25, 50 Novo penmix insulin (30,40,50); Mixtard (only 10ml) Novomix30
13 A1 Lys Pro Thr Thr Arg Ala His His Asn B1 Asn Asn Ile Thr lle B20 A21 B28 B30 Human Insulin
14 Pro Lys Thr Thr Arg Ala His His Asn B1 Asn Asn Ile Thr lle A21 B28 A1 B30 B20 Insulin Lispro
15 Thr Lys Asp Thr Arg Ala His His Asn B1 Asn Asn Ile Thr lle A21 B28 Asp Pro Insulin Aspart A1 B30 B20
16 Pro Thr Thr Arg Ala His His Lys B1 Asn Asn Ile Thr lle A21 B28 A1 B30 B20 Insulin lisine Lys Asn
17 Rapid absorbing analogs Aspart substitutes b28 proline with aspartic acid Lispro reverses b29 lysine with b28 proline lisine substitutes b3 asparagine with Lysine and b29 lysine with glutamic acid
18 A1 Lys Pro Thr Thr Arg Ala His His Asn B1 Asn Ile Thr lle B20 A21 B28 B30 Insulin Glargine Arg Arg
19
20 Glargine: a21 asparagine replaced with glycine and 2 arginines added at positions b31 and 32 Determir: insulin linked to myristic acid
21 Change in um Insulin Human Insulin Time-Action Patterns Normal insulin secretion at mealtime Theoretical representation of expected insulin release in nondiabetic subjects Baseline Level SC injection Time (hours)
22 Change in um Insulin Human Insulin Time-Action Patterns Normal insulin secretion at mealtime Regular insulin (human) Theoretical representation of profile associated with regular insulin (human) Baseline Level Time (hours) SC injection Need to inject 45 mins before meal to get in phase
23 Change in um Insulin Analog Insulin Time-Action Patterns Normal insulin secretion at mealtime Insulin analog Humalog or NovoRapid Theoretical representation of profile associated with insulin analog premix Baseline Level Time (hours) SC injection 20 mins to get in phase; 2-3 hours duration
24 Change in um Insulin NPH Insulin variation by day Normal insulin secretion at mealtime NPH insulin (human) Theoretical representation of profile associated with NPH insulin Baseline Level Time (hours) SC injection CV of absorption profile approaches 100%
25 Change in um Insulin Glargine Insulin Time-Action Patterns Normal insulin secretion at mealtime QD basal glargine insulin Theoretical representation of profile associated with basal analog insulin Baseline Level SC injection Time (hours) ~20% will have shorter absorption patterns; 2x daily works better in such people but still relatively peakless cf NPH and much lower CV
26 Truths: Insulin Insulin is absorbed variably in the same patient on different days The longer the action the greater the variability except for glargine and detemir Insulin is absorbed differently patient to patient Most insulin are absorbed differently at various anatomical sites External conditions of heat, stress, food, illness etc alter absorption parameters The volume injected alters absorption Local tissue proteases can destroy injected insulin All insulins cause antibody manufacture which may be high/low affinity..high/low capacity interfering with action Insulin sub-cut therapy is non-physiological and is a poor replacement option (so keep some B cells alive at all cost)
27 Insulin Myths : Rapid absorbing Insulin can be given with best effect a few minutes before food. Rapid acting, slow acting misleading terminology absorption is what is meant Long absorbing Insulins can always be given once daily for best effect Long absorbing insulins are completely peakless (Glargine is to all intents peakless; duration of plateau does vary however)
28 A snapshot of pharmacokinetics Property Glargine NPH End of action (viz all gone) 22 +/- 4 hrs 14 +/- 3 Onset 1.5 +/- 0.3 hrs 0.8 +/- 0.2 Duration of action /-3.7 hrs /-2.8 Anatomical site absorption variation No yes Peak Minimal (plateau) 4-8 hr Accumulation over time nil yes Mean +/- SEM in 20 subjects Diabetes 49: 2142, 2000
29 Questions and discussion
Insulin analogues Das PP, Datta PG
The ORION Medical Journal 2007 Sep;28:497-500 Insulin analogues Das PP, Datta PG Introduction Diabetes mellitus is a very big challenge for our medical science. To overcome this problem we need newer generation
More informationINSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.
INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationAgenda. Indications Different insulin preparations Insulin initiation Insulin intensification
Insulin Therapy F. Hosseinpanah Obesity Research Center Research Institute for Endocrine sciences Shahid Beheshti University of Medical Sciences November 11, 2017 Agenda Indications Different insulin preparations
More informationType I Type II Insulin Resistance
Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100
More informationInsulin Analogs & Premixed Insulin Analogs
Rationale for the Development and Clinical Use of Insulin Analogs & Premixed Insulin Analogs A continuing education monograph for pharmacists, nurses, and dietitians this CE activity can also be completed
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationDisclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2
Therapy For Diabetes Michigan Association of Osteopathic Family Physicians Mid-Winter Family Medicine Update Shanty Creek Resort, MI January 19-22nd 2017 Michael R. Brennan D.O., M.S., F.A.C.E Director
More informationINSULIN 101: When, How and What
INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form
More informationType 2 Diabetes Mellitus Insulin Therapy 2012
Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationPranay wal et al, /J. Pharm. Sci. & Res. Vol.2(5), 2010,
Comparative efficacy of humalog mix 75/25 with human Insulin. Pranay wal 1 *, Ankita wal 2, Shivangi Srivastava 2,Abhinav srivastava 2, Umeshwar Pandey 3, Tarun Jain 1, Awani k Rai 2. 1 Jodhpur National
More informationInsulin Regimens: Hitting Glycemia Targets
Insulin Regimens: Hitting Glycemia Targets Grant Kelley MD March 1 st, 2018 Faculty Disclosure: Financial relationships with commercial interests None Overview Mortality and Morbidity Insulin and Insulin
More informationInsulin Therapy Management. Insulin Therapy
Insulin Therapy Management Insulin Therapy Contents Insulin and its effect on glycemic control Physiology of insulin secretion Insulin pharmacokinetics and regimens Insulin dose adjustment for pregnancy
More informationCase Study: Competitive exercise
Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) June 2017 Review: June 2020 (earlier if required see recommendations) Bulletin 255: Insulin aspart New Formulation - Fiasp JPC Recommendations:
More informationIn-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University
In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with
More informationINSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد
INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid
More informationInjecting Insulin into Out Patient Practice
Injecting Insulin into Out Patient Practice Kathleen Colleran, MD Associate Professor UNMHSC 4/22/10 Overview Natural history of Type 2 diabetes Reasons clinicians are reluctant to start insulin therapy
More informationJanuary 7, 5:00 p.m. EST
Study 3-151 Phase 2 Trial: Preliminary Results BIOD-531, a Concentrated Ultra-Rapid-Acting Prandial/Basal Insulin, Demonstrates Superior Post-Meal Glucose Control Compared to Marketed Prandial/Basal Insulins
More informationProviding Stability to an Unstable Disease
Basal Insulin Therapy Providing Stability to an Unstable Disease Thomas A. Hughes, M.D. Professor of Medicine - Retired Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More information8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy
Insulin Basics Anabolic hormone involved in metabolism Following carbohydrate ingestion insulin release is stimulated Suppresses hepatic glucose production Stimulates peripheral glucose uptake Commercially-available
More informationNovel Formulations to Modify Mealtime Insulin Kinetics
Novel Formulations to Modify Mealtime Insulin Kinetics Alan Krasner, Roderike Pohl, Patrick Simms, Philip Pichotta, Robert Hauser, Errol De Souza Biodel, Inc. Danbury, CT Disclosure All authors are employees
More informationA review of insulin and insulin regimens in type 2 diabetes
A review of insulin and insulin regimens in type 2 diabetes Joshi S, MBChB, MSc(Pharm) Med, APLS Joshi P*, PhD, FRCP, FRS Med, FICA, MACE Diabetes Care Centre, Louis Pasteur Medical Centre, Pretoria *Emeritus
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationInsulin Management. By Susan Henry Diabetes Specialist Nurse
Insulin Management By Susan Henry Diabetes Specialist Nurse The Discovery of Insulin - 1921 - Banting & Best University Of Toronto Discovered hormone insulin in pancreatic extract of dog - Marjorie the
More informationDiabetes, Type 2 Management
CLINICAL GUIDELINE Diabetes, Type 2 Management A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability
More informationObjectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17
Objectives Compare and contrast currently available products. Navigating New s Diana Isaacs, PharmD, BCPS, BC-ADM, CDE Clinical Pharmacy Specialist Cleveland Clinic Diabetes Center Determine the factors
More informationNew basal insulins Are they any better? Matthew C. Riddle, MD Professor of Medicine Oregon Health & Science University Keystone Colorado 15 July 2011
New basal insulins Are they any better? Matthew C. Riddle, MD Professor of Medicine Oregon Health & Science University Keystone Colorado 15 July 2011 Presenter Disclosure I have received the following
More informationClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
More informationMANAGEMENT OF DIABETES IN PREGNANCY
MANAGEMENT OF DIABETES IN PREGNANCY Ministry of Health Malaysia Malaysian Endocrine & Metabolic Society Perinatal Society of Malaysia Family Medicine Specialists Association of Malaysia Academy of Medicine
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION This module reflects the initial scientific discussion for the approval of Novomix. This scientific discussion has been updated until 1 September 2004. For information on changes
More informationUpdate on Insulin-based Agents for T2D
Update on Insulin-based Agents for T2D Injectable Therapies for Type 2 Diabetes Mellitus (T2DM) and Obesity This presentation will: Describe established and newly available insulin therapies for treatment
More informationInitiation and Adjustment of Insulin Regimens for Type 2 Diabetes
Types of Insulin Rapid-acting insulin: lispro (Humalog), aspart (NovoRapid), glulisine (Apidra) Regular short-acting insulin: Humulin R, Novolin ge Toronto, Hypurin Regular Basal insulin: NPH (Humulin
More informationTips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital
Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure
More informationPathogenesis of Type 1 Diabetes. Diabetes Mellitus Type 1. Pathogenesis. Pathogenesis of DM1. Type 2. Type 1. Genetics of Type 1 Diabetes
Pathogenesis of Type 1 Diabetes Diabetes Mellitus Type 1 D G V A N ZYL Genetics of Type 1 Diabetes Pathogenesis Complex and poorly understood interplay between genetics and environmental factors Monozycotic
More information6: Uses of insulin in treatment of diabetes
6: Uses of insulin in treatment of diabetes objectives 1. Define diabetes and mention different types of diabetes 2. Differentiate between difference in treating type I and type II diabetes. 3. Understand
More informationUpdate on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy
Update on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy Jerry Meece, BPharm, CDE, FACA, FAADE Director of Clinical Services Plaza Pharmacy and Wellness Center Gainesville,
More informationLegal Status Indication Treatment of Type 1 and Type 2 diabetes
New Medicine Report (Adopted by the CCG until review and further notice) Document Status Recombinant human insulin analogues Following Suffolk D&TC Meeting Traffic Light Decision Green Date of Last Revision
More informationA Fact Sheet for Parents and Carers Insulin and Diabetes
A Fact Sheet for Parents and Carers Insulin and Diabetes In type 1 diabetes the body stops producing insulin. Insulin therapy is essential in the treatment of type 1 diabetes, together with a healthy eating
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider
More informationDiabetes Head to Toe May 31, 2017
Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing
More informationObjectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment
Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Judy Thomas, MSN, FNP-BC Holt and Walton, Rheumatology and Endocrinology Objectives Upon completion of this session you will be better
More informationInsulin therapy in gestational diabetes mellitus
Insulin therapy in gestational diabetes mellitus October 15, 2015 Kyung-Soo Kim Division of Endocrinology & Metabolism, Department of Internal Medicine, CHA Bundang Medical Center, CHA University Contents
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Think about when / why patients require insulin therapy
More informationPHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationReviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate
Reviewing Diabetes Guidelines Newsletter compiled by Danny Jaek, Pharm.D. Candidate AL AS KA N AT IV E DI AB ET ES TE A M Volume 6, Issue 1 Spring 2011 Dia bet es Dis pat ch There are nearly 24 million
More informationConverting lantus to humalog 75 25
P ford residence southampton, ny Converting lantus to humalog 75 25 This page includes the following topics and synonyms: Insulin Dosing in Type 2 Diabetes, Insulin Dosing in Type II Diabetes. Thiazide
More informationNew Drug Evaluation: Insulin degludec/aspart, subcutaneous injection
New Drug Evaluation: Insulin degludec/aspart, subcutaneous injection Date of Review: March 2016 End Date of Literature Search: November 11, 2015 Generic Name: Insulin degludec and insulin aspart Brand
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationMANAGEMENT OF TYPE 1 DIABETES MELLITUS
MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationNph insulin conversion to lantus
Nph insulin conversion to lantus Search 26-2-2003 RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin.
More informationInsulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children December 2008 This technology summary is based on information available at the time of research and a limited literature
More information24 Hour Support. Telephone Available 24 hours a day, 7 days a week
Contents Page What is SHAIRE? 1 What is basal-bolus regimen? 2 Why do I need a basal-bolus regimen? 3 How does basal insulin work? 3 How does rapid-acting insulin work? 4 How often should I test my Blood
More informationMixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
More informationStroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke
More informationLET S TALK INSULIN THE BASICS
LET S TALK INSULIN THE BASICS AUTHOR S DISCLOSURES Contracted for program development for Lifescan Canada Speaker for Lifescan, Lilly, BI, Consultant for Lilly, Janssen, Novo Nordisk, Lifescan Canada OBJECTIVES
More informationInsulin Initiation, titration & Insulin switch in the Primary Care-KISS
Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda
More informationUKPDS: Over Time, Need for Exogenous Insulin Increases
UKPDS: Over Time, Need for Exogenous Insulin Increases Patients Requiring Additional Insulin (%) 60 40 20 Oral agents By 6 Chlorpropamide years, Glyburide more than 50% of UKPDS patients required insulin
More informationBasal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January
Basal-Bolus Insulin Therapy Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January 18 2018 Terminology No longer using the term diabetic. Diabetes does not define people. People with diabetes are individuals
More informationInpatient Glycemic Management:
Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures: Dr. Seley attended Advisory Board Meeting: Alliance (Boehringer-Ingelheim/Lilly) Bayer Diabetes Care Sanofi
More informationPHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationBasal Bolus Insulin Therapy Frequently Asked Questions
1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong
More informationPRINCIPLES OF INSULIN THERAPY
08 PRINCIPLES OF INSULIN THERAPY 8.1 GENERAL PRINCIPLES 8.1.1 Indications of Insulin Therapy The classical type 1 diabetes mellitus and LADA cases Hyperglycemic emergencies (DKA, HHS) Some cases of type
More informationLearning Objectives. Are you ready for more insulin formulations?
Are you ready for more insulin formulations? Shara Elrod, PharmD, BCACP, BCGP Learning Objectives Review pharmacology and dosing of new insulin formulations Compare and contrast new insulin formulations
More informationPoll Question 2. Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services.
Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Poll Question 1 Mary takes 6 units lispro (Humalog) before dinner. Which BG result reflects
More informationSCIENTIFIC DISCUSSION
London, 5 October 2005 Product name: NovoMix Procedure No. EMEA/H/C/308/X/18 SCIENTIFIC DISCUSSION 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68
More informationInpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin
Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used
More informationAmino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3
Fundamentals While their name implies that amino acids are compounds that contain an 2 group and a 2 group, these groups are actually present as 3 and 2 respectively. They are classified as α, β, γ, etc..
More informationConcomitant Use of Insulin Glargine and NPH in Type I Diabetes
responses to treatment including ritonavir or nelfinavir in HIV-1-infected children. Pediatric AIDS Group of Switzerland. Infection 2000; 28: 287-296. 12. Saez-Llorens X, Violari A, Deetz CO, Rode RA,
More informationThe principles of insulin adjustment guidance
The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according
More informationInsulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology
Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss
More informationUpdate on Insulin-based Agents for T2D. Harry Jiménez MD, FACE
Update on Insulin-based Agents for T2D Harry Jiménez MD, FACE Harry Jiménez MD, FACE Has received honorarium as Speaker and/or Consultant for the following pharmaceutical companies: Eli Lilly Merck Boehringer
More informationAmino acids-incorporated nanoflowers with an
Amino acids-incorporated nanoflowers with an intrinsic peroxidase-like activity Zhuo-Fu Wu 1,2,+, Zhi Wang 1,+, Ye Zhang 3, Ya-Li Ma 3, Cheng-Yan He 4, Heng Li 1, Lei Chen 1, Qi-Sheng Huo 3, Lei Wang 1,*
More informationSponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More informationFaculty. Concentrated Insulin: Examining the Necessity of Newer Insulins for In-Hospital Diabetes Management. Disclosures. Learning Objectives
Examining the Necessity of Newer Insulins for In-Hospital Diabetes Management Faculty Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Professor of Pharmacy Practice Associate Director of Experiential
More informationStarting Insulin in General Practice
Starting Insulin in General Practice Timothy Kenealy GP & Assoc Prof of Integrated Care, University of Auckland Auckland DHB / my version + Counties DHB version Starting Insulin surprisingly simple, safe
More informationRole of Insulin Analogs in
Role of Insulin Analogs in Type 2 Diabetes Supported by an educational grant from Novo Nordisk Inc. This program is supported by an educational grant from Novo Nordisk Inc. It has been accredited by the
More informationInsulin analogues and their potential in the management of diabetes mellitus
Diabetologia (1999) 42: 1151±1167 Ó Springer-Verlag 1999 Review Insulin analogues and their potential in the management of diabetes mellitus G.B. Bolli 1, R. D. Di Marchi 2, G. D. Park 3, S. Pramming 4,
More informationPremixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s
Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationA Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Diabetes Ther (2018) 9:927 949 https://doi.org/10.1007/s13300-018-0422-4 REVIEW A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus Riccardo
More informationComparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary
Number 14 Effective Health Care Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary Background and Key Questions
More informationInsulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin
Patient Education Insulin Basic facts Insulin is a protein made by the pancreas that allows your cells to use glucose for energy. There are different types of insulin: Basal long-acting insulin that controls
More informationDIABETES INDICATIONS FOR INSULIN
DIABETES INDICATIONS FOR INSULIN 1 Introduce the likely need for insulin in the future early on as part of patient education Emphasise that it is the pancreas that fails not the patient Assess if greater
More information1. Describe the relationship of dietary protein and the health of major body systems.
Food Explorations Lab I: The Building Blocks STUDENT LAB INVESTIGATIONS Name: Lab Overview In this investigation, you will be constructing animal and plant proteins using beads to represent the amino acids.
More informationInsulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products
Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products FDA LABELED INDICATIONS 1-13,16-21 Rapid-Acting Indication Onset Peak Duration Insulins Admelog (insulin
More informationInsulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products
Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products FDA LABELED INDICATIONS 1-13,16-20 Rapid-Acting Indication Onset Peak Duration Insulins Fiasp (insulin
More informationBon Secours Richmond Pharmacy & Therapeutics Committees Biphasic Insulin Mixes: Humalog Mix 75/25, NovoLog Mix 70/30, Novolin 70/30
Bon Secours Richmond Pharmacy & Therapeutics Committees Biphasic Insulin Mixes: Humalog Mix 75/25, NovoLog Mix 70/30, Novolin 70/30 Recommendations: MEC Approved MRMC, SMH NovoLog Mix 70/30 will be used
More informationInsulin and human growth hormone
Pharmaceutical Biotechnology Insulin and human growth hormone By Yuqiong Xia Keywords Insulin, pancreatic, glucagon, diabetes, zinc, protamine peak, maximum, crystallization, acid Human growth factor,
More informationHow to Fight Diabetes and Win. Diabetes. Medications
How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationNew Therapies for Diabetes Management: Hope or Headache?
New Therapies for Diabetes Management: Hope or Headache? Elizabeth Stephens, MD, FACP PMG- Endocrinology Elizabeth.Stephens@providence.org November 2018 Disclosures None 1 Objectives Discussion of 3 rd
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationMedications for Diabetes
Medications for Diabetes Sweet, but not too sweet Colette Raymond, Pharm D June 15, 2011 Learning Objectives At the end of this presentation you should be able to: Understand the prevalence and types of
More informationDrug Effectiveness Review Project Summary Report Long acting Insulins
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationOTE HAR M A. Insulin degludec (Tresiba ): Ultralong. basal insulin with less nocturnal hypoglycemia than glargine.
HAR M A Vol. 31, Issue 5 February 2016 N OTE Established 1985 Insulin degludec (Tresiba ): Ultra-long basal insulin with less nocturnal hypoglycemia than glargine Brian Nocito, PharmD Candidate D iabetes
More information